Clinical and therapeutic aspects of extrapulmonary small cell carcinoma

Cancer Treatment Reviews

Volumn 35, Issue 3, 2009, Pages 228-236

  Walenkamp, Annemiek M E ^a   Sonke, Gabe S ^b   Sleijfer, Dirk T ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b ANTONI VAN LEEUWENHOEK HOSPITAL   (Netherlands)

Author keywords

Extrapulmonary small cell carcinoma treatment; Prophylactic cranial irradiation

Indexed keywords

CARBOPLATIN; CISPLATIN; CYCLOPHOSPHAMIDE; DOCETAXEL; DOXORUBICIN; ETOPOSIDE; GEMCITABINE; IFOSFAMIDE; IRINOTECAN; NAVELBINE; PLATINUM; TENIPOSIDE; TOPOTECAN; VINCRISTINE;

BLADDER CARCINOMA; BRAIN METASTASIS; CANCER INCIDENCE; CANCER OF UNKNOWN PRIMARY SITE; CANCER RECURRENCE; CANCER REGRESSION; CANCER STAGING; CENTRAL NERVOUS SYSTEM METASTASIS; CLINICAL TRIAL; CYSTECTOMY; DISEASE FREE SURVIVAL; DISTANT METASTASIS; DRUG EFFICACY; ESOPHAGUS CARCINOMA; GASTROINTESTINAL CARCINOMA; HEAD AND NECK CARCINOMA; HUMAN; LUNG SMALL CELL CANCER; MICROMETASTASIS; MULTIMODALITY CANCER THERAPY; MULTIPLE CYCLE TREATMENT; OVERALL SURVIVAL; PROGNOSIS; PROSTATE CARCINOMA; REVIEW; SKULL IRRADIATION; SMALL CELL CARCINOMA; SURVIVAL RATE; UROGENITAL TRACT CANCER; UTERINE CERVIX CARCINOMA;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BRAIN NEOPLASMS; CARCINOMA, SMALL CELL; COMBINED MODALITY THERAPY; CRANIAL IRRADIATION; FEMALE; GASTROINTESTINAL NEOPLASMS; HEAD AND NECK NEOPLASMS; HUMANS; MALE; NEOPLASM STAGING; NEOPLASMS, UNKNOWN PRIMARY; ORGAN SPECIFICITY; PROGNOSIS; UROGENITAL NEOPLASMS;

EID: 64049102123     PISSN: 03057372     EISSN: 15321967     Source Type: Journal    
DOI: 10.1016/j.ctrv.2008.10.007     Document Type: Review

References (117)

1. Duguid J., and Kennedy A. Oat cell tumors in mediastinal glands. J Pathol Bacteriol 33 (1930) 93-99
2. Haider K., Shahid R.K., Finch D., et al. Extrapulmonary small cell cancer: a Canadian province's experience. Cancer 107 (2006) 2262-2269
3. Brenner B., Shah M.A., Gonen M., Klimstra D.S., Shia J., and Kelsen D.P. Small-cell carcinoma of the gastrointestinal tract: a retrospective study of 64 cases. Br J Cancer 90 (2004) 1720-1726
4. Shahab N. Extrapulmonary small cell carcinoma of the bladder. Sem Oncol 34 (2007) 15-21
5. Lee S.S., Lee J.L., Ryu M.H., et al. Extrapulmonary small cell carcinoma: single center experience with 61 patients. Acta Oncol 46 (2007) 846-851
6. Ferlito A., and Rinaldo A. Primary and secondary small cell neuroendocrine carcinoma of the larynx: a review. Head Neck 30 (2008) 518-524
7. Hainsworth J.D., Johnson D.H., and Greco F.A. Poorly differentiated neuroendocrine carcinoma of unknown primary site. A newly recognized clinicopathologic entity. Ann Int Med 109 (1988) 364-371
8. Levenson Jr. R.M., Ihde D.C., Matthews M.J., et al. Small cell carcinoma presenting as an extrapulmonary neoplasm: sites of origin and response to chemotherapy. J Natl Cancer Inst 67 (1981) 607-612
9. Remick S.C., and Ruckdeschel J.C. Extrapulmonary and pulmonary small-cell carcinoma: tumor biology, therapy, and outcome. Med Pediatr Oncol 20 (1992) 89-99
10. Chua Y.J., Steer C., and Yip D. Recent advances in management of small-cell lung cancer. Cancer Treat Rev 30 (2004) 521-543
11. Galanis E., Frytak S., and Lloyd R.V. Extrapulmonary small cell carcinoma. Cancer 79 (1997) 1729-1736
12. Cicin I., Karagol H., Uzunoglu S., et al. Extrapulmonary small-cell carcinoma compared with small-cell lung carcinoma: a retrospective single-center study. Cancer 110 (2007) 1068-1076
13. Frazier S.R., Kaplan P.A., and Loy T.S. The pathology of extrapulmonary small cell carcinoma. Sem Oncol 34 (2007) 30-38
14. Fischer B.M., Mortensen J., Langer S.W., et al. A prospective study of PET/CT in initial staging of small-cell lung cancer: comparison with CT, bone scintigraphy and bone marrow analysis. Ann Oncol 18 (2007) 338-345
15. Samson D.J., Seidenfeld J., Simon G.R., et al. Evidence for management of small cell lung cancer: ACCP evidence-based clinical practice guidelines (2nd ed.). Chest 132 (2007) 314S-323S
16. Agra Y., Pelayo M., Sacristan M., Sacristan A., Serra C., and Bonfill X. Chemotherapy versus best supportive care for extensive small cell lung cancer. Cochrane Database Syst Rev (2003) CD001990
17. Comis R.L., Friedland D.M., and Good B.C. Small-cell lung cancer: a perspective on the past and a preview of the future. Oncology (Williston Park) 12 (1998) 44-50
18. Pignon J.P., Arriagada R., Ihde D.C., et al. A meta-analysis of thoracic radiotherapy for small-cell lung cancer. N Engl J Med 327 (1992) 1618-1624
19. Warde P., and Payne D. Does thoracic irradiation improve survival and local control in limited-stage small-cell carcinoma of the lung? A meta-analysis. J Clin Oncol 10 (1992) 890-895
20. Skarlos D.V., Samantas E., Kosmidis P., et al. Randomized comparison of etoposide-cisplatin vs. etoposide-carboplatin and irradiation in small-cell lung cancer. A Hellenic co-operative oncology group study. Ann Oncol 5 (1994) 601-607
21. Lassen U.N., Kristjansen P.E., Osterlind K., et al. Superiority of cisplatin or carboplatin in combination with teniposide and vincristine in the induction chemotherapy of small-cell lung cancer. A randomized trial with 5 years follow up. Ann Oncol 7 (1996) 365-371
22. Noda K., Nishiwaki Y., Kawahara M., et al. Irinotecan plus cisplatin compared with etoposide plus cisplatin for extensive small-cell lung cancer. N Engl J Med 346 (2002) 85-91
23. Hanna N., Bunn Jr. P.A., Langer C., et al. Randomized phase III trial comparing irinotecan/cisplatin with etoposide/cisplatin in patients with previously untreated extensive-stage disease small-cell lung cancer. J Clin Oncol 24 (2006) 2038-2043
24. Hermes A., Bergman B., Bremnes R., et al. Irinotecan plus carboplatin versus oral etoposide plus carboplatin in extensive small-cell lung cancer: a randomized phase III trial. J Clin Oncol 26 (2008) 4261-4267
25. Gandara D.R., Lara Jr. P.N., Natale R., and Belani C. Progress in small-cell lung cancer: the lowest common denominator. J Clin Oncol 26 (2008) 4236-4238
26. Elias A. Hematopoietic stem cell transplantation for small cell lung cancer. Chest 116 (1999) 531S-538S
27. McCracken J.D., Janaki L.M., Crowley J.J., et al. Concurrent chemotherapy/radiotherapy for limited small-cell lung carcinoma: a southwest oncology group study. J Clin Oncol 8 (1990) 892-898
28. Takada M., Fukuoka M., Kawahara M., et al. Phase III study of concurrent versus sequential thoracic radiotherapy in combination with cisplatin and etoposide for limited-stage small-cell lung cancer: results of the Japan clinical oncology group study 9104. J Clin Oncol 20 (2002) 3054-3060
29. Spiro S.G., Souhami R.L., Geddes D.M., et al. Duration of chemotherapy in small cell lung cancer: a cancer research campaign trial. Br J Cancer 59 (1989) 578-583
30. O'Brien M., Ciuleanu T., Tsekov H., et al. Phase III trial comparing supportive care alone with supportive care with oral topotecan in patients with relapsed small-cell lung cancer. J Clin Oncol 24 (2006) 5441-5447
31. Smit E.F., Fokkema E., Biesma B., Groen H.J., Snoek W., and Postmus P.E. A phase II study of paclitaxel in heavily pretreated patients with small-cell lung cancer. Br J Cancer 77 (1998) 347-351
32. Smyth J.F., Smith I.E., Sessa C., et al. Activity of docetaxel (taxotere) in small cell lung cancer. The early clinical trials group of the EORTC. Eur J Cancer 30 (1994) 1058-1060
33. Einhorn L.H., Pennington K., and McClean J. Phase II trial of daily oral VP-16 in refractory small cell lung cancer: a Hoosier oncology group study. Sem Oncol 17 (1990) 32-35
34. Furuse K., Kubota K., Kawahara M., et al. Phase II study of vinorelbine in heavily previously treated small cell lung cancer. Japan lung cancer Vinorelbine study group. Oncology 53 (1996) 169-172
35. Jassem J., Karnicka-Mlodkowska H., van Pottelsberghe C., et al. Phase II study of vinorelbine (Navelbine) in previously treated small cell lung cancer patients. EORTC lung cancer cooperative group. Eur J Cancer 29 (1993) 1720-1722
36. Masters G.A., Declerck L., Blanke C., et al. Phase II trial of gemcitabine in refractory or relapsed small-cell lung cancer: eastern cooperative oncology group trial 1597. J Clin Oncol 21 (2003) 1550
37. Postmus P.E., Berendsen H.H., van Zandwijk N., Splinter T.A., Burghouts J.T., and Bakker W. Retreatment with the induction regimen in small cell lung cancer relapsing after an initial response to short term chemotherapy. Eur J Cancer Clin Oncol 23 (1987) 1409-1411
38. Vincent M., Evans B., and Smith I. First-line chemotherapy rechallenge after relapse in small cell lung cancer. Cancer Chemother Pharmacol 21 (1988) 45-48
39. Shepherd F.A., Evans W.K., MacCormick R., Feld R., and Yau J.C. Cyclophosphamide, doxorubicin, and vincristine in etoposide-and cisplatin-resistant small cell lung cancer. Cancer Treat Rep 71 (1987) 941-944
40. Murray N., Livingston R.B., Shepherd F.A., et al. Randomized study of CODE versus alternating CAV/EP for extensive-stage small-cell lung cancer: an intergroup study of the National Cancer Institute of Canada clinical trials group and the southwest oncology group. J Clin Oncol 17 (1999) 2300
41. Einhorn L.H., and Loehrer P.J. Hoosier oncology group studies in extensive and recurrent small cell lung cancer. Sem Oncol 22 (1995) 28-31
42. Redman B.G., and Pazdur R. Colonic small cell undifferentiated carcinoma: a distinct pathological diagnosis with therapeutic implications. Am J Gastroenterol 82 (1987) 382-385
43. Wick M.R., Weatherby R.P., and Weiland L.H. Small cell neuroendocrine carcinoma of the colon and rectum: clinical, histologic, and ultrastructural study and immunohistochemical comparison with cloacogenic carcinoma. Hum Pathol 18 (1987) 9-21
44. O'Byrne K.J., Cherukuri A.K., Khan M.I., et al. Extrapulmonary small cell gastric carcinoma. A case report and review of the literature. Acta Oncol 36 (1997) 78-80
45. Casas F., Ferrer F., Farrus B., Casals J., and Biete A. Primary small cell carcinoma of the esophagus: a review of the literature with emphasis on therapy and prognosis. Cancer 80 (1997) 1366-1372
46. Medgyesy C.D., Wolff R.A., Putnam Jr. J.B., and Ajani J.A. Small cell carcinoma of the esophagus: the University of Texas M.D. Anderson cancer center experience and literature review. Cancer 88 (2000) 262-267
47. Ku G.Y., Minsky B.D., Rusch V.W., Bains M., Kelsen D.P., and Ilson D.H. Small-cell carcinoma of the esophagus and gastroesophageal junction: review of the Memorial Sloan-Kettering experience. Ann Oncol 19 (2008) 533-537
48. Brenner B., Tang L.H., Shia J., Klimstra D.S., and Kelsen D.P. Small cell carcinomas of the gastrointestinal tract: clinicopathological features and treatment approach. Sem Oncol 34 (2007) 43-50
49. Arai K., and Matsuda M. Gastric small-cell carcinoma in japan: a case report and review of the literature. Am J Clin Oncol 21 (1998) 458
50. Matsui K., Jin X.M., Kitagawa M., and Miwa A. Clinicopathologic features of neuroendocrine carcinomas of the stomach: appraisal of small cell and large cell variants. Arch Pathol Lab Med 122 (1998) 1010-1017
51. Matsui K., Kitagawa M., Miwa A., Kuroda Y., and Tsuji M. Small cell carcinoma of the stomach: a clinicopathologic study of 17 cases. Am J Gastroenterol 86 (1991) 1167-1175
52. Yaziji H., and Broghamer W.L. Primary small cell undifferentiated carcinoma of the rectum associated with ulcerative colitis. South Med J 89 (1996) 921
53. Hung S.S. Small cell carcinoma of the colon. A case report and literature review. J Clin Gastroenterol 11 (1989) 335-339
54. Shirouzu K., Morodomi T., Isomoto H., Yamauchi Y., Kakegawa T., and Morimatsu M. Small-cell carcinoma of the rectum. Dis Colon Rectum 28 (1985) 434-439
55. Burke A.B., Shekitka K.M., and Sobin L.H. Small cell carcinomas of the large intestine. Am J Clin Pathol 95 (1991) 315-321
56. Bernick P.E., Klimstra D.S., Shia J., et al. Neuroendocrine carcinomas of the colon and rectum. Dis Colon Rectum 47 (2004) 163-169
57. Fujii H., Aotake T., Horiuchi T., Chiba Y., Imamura Y., and Tanaka K. Small cell carcinoma of the gallbladder: a case report and review of 53 cases in the literature. Hepatogastroenterology 48 (2001) 1588-1593
58. Renner G. Small cell carcinoma of the head and neck: a review. Sem Oncol 34 (2007) 3-14
59. Gnepp D.R. Small cell neuroendocrine carcinoma of the larynx. A critical review of the literature. ORL J Otorhinolaryngol Relat Spec 53 (1991) 210-219
60. Ferlito A., Barnes L., Rinaldo A., Gnepp D.R., and Milroy C.M. A review of neuroendocrine neoplasms of the larynx: update on diagnosis and treatment. J Laryngol Otol 112 (1998) 827-834
61. Baugh R.F., Wolf G.T., and McClatchey K.D. Small cell carcinoma of the head and neck. Head Neck Surg 8 (1986) 343-354
62. Aguilar E.A., Robbins K.T., Stephens J., Dimery I.W., and Batsakis J.G. Primary oat cell carcinoma of the larynx. Am J Clin Oncol 10 (1987) 26
63. Barker Jr. J.L., Glisson B.S., Garden A.S., et al. Management of nonsinonasal neuroendocrine carcinomas of the head and neck. Cancer 98 (2003) 2322-2328
64. Nagao T., Gaffey T.A., Olsen K.D., Serizawa H., and Lewis J.E. Small cell carcinoma of the major salivary glands: clinicopathologic study with emphasis on cytokeratin 20 immunoreactivity and clinical outcome. Am J Surg Pathol 28 (2004) 762
65. De Vicente Rodríguez J.F., Fresno Forcelledo M.F., Junquera Gutiérrez L.M., Vallejo G.H., and López Arranz J.S. Small cell undifferentiated carcinoma of the submandibular gland with neuroendocrine features. Ann Otol Rhinol Laryngol 113 (2004) 55-59
66. Ellis GL, Auclair PL. Atlas of tumor pathology; 1996. p. 155-373.
67. Scher R.L., Feldman P.S., and Levine P.A. Small-cell carcinoma of the parotid gland with neuroendocrine features. Arch Otolaryngol Head Neck Surg 114 (1988) 319-321
68. Gnepp D.R., Ferlito A., and Hyams V. Primary anaplastic small cell (oat cell) carcinoma of the larynx. Review of the literature and report of 18 cases. Cancer 51 (1983) 1731-1745
69. Lin Y.C., Wu H.P., and Tzeng J.E. Small-cell undifferentiated carcinoma of the submandibular gland: an extremely rare extrapulmonary site. Am J Otolaryngol 26 (2005) 60-63
70. Rosenthal D.I., Barker Jr. J.L., El-Naggar A.K., et al. Sinonasal malignancies with neuroendocrine differentiation: patterns of failure according to histologic phenotype. Cancer 101 (2004) 2567-2573
71. Lohrisch C., Murray N., Pickles T., and Sullivan L. Small cell carcinoma of the bladder: long term outcome with integrated chemoradiation. Cancer 86 (1999) 2346-2352
72. Mangar S.A., Logue J.P., Shanks J.H., Cooper R.A., Cowan R.A., and Wylie J.P. Small-cell carcinoma of the urinary bladder: 10-year experience. Clin Oncol (R Coll Radiol) 16 (2004) 523-527
73. Grignon D.J., Ro J.Y., Ayala A.G., et al. Small cell carcinoma of the urinary bladder. A clinicopathologic analysis of 22 cases. Cancer 69 (1992) 527-536
74. Bex A., Nieuwenhuijzen J.A., Kerst M., et al. Small cell carcinoma of bladder: a single-center prospective study of 25 cases treated in analogy to small cell lung cancer. Urology 65 (2005) 295-299
75. Cheng L., Pan C.X., Yang X.J., et al. Small cell carcinoma of the urinary bladder: a clinicopathologic analysis of 64 patients. Cancer 101 (2004) 957-962
76. Holmang S., and Johansson S.L. Stage Ta-T1 bladder cancer: the relationship between findings at first followup cystoscopy and subsequent recurrence and progression. J Urol 167 (2002) 1634-1637
77. Choong N.W., Quevedo J.F., and Kaur J.S. Small cell carcinoma of the urinary bladder. The Mayo clinic experience. Cancer 103 (2005) 1172-1178
78. Mackey J.R., Au H.J., Hugh J., and Venner P. Genitourinary small cell carcinoma: determination of clinical and therapeutic factors associated with survival. J Urol 159 (1998) 1624-1629
79. Siefker-Radtke A.O., Dinney C.P., Abrahams N.A., et al. Evidence supporting preoperative chemotherapy for small cell carcinoma of the bladder: a retrospective review of the M.D. Anderson cancer experience. J Urol 172 (2004) 481-484
80. Holmang S., Borghede G., and Johansson S.L. Primary small cell carcinoma of the bladder: a report of 25 cases. J Urol 153 (1995) 1820-1822
81. Davis M.P., Murthy M.S., Simon J., Wise H., and Minton J.P. Successful management of small cell carcinoma of the bladder with cisplatin and etoposide. J Urol 142 (1989) 817
82. Crowder S., and Tuller E. Small cell carcinoma of the female genital tract. Sem Oncol 34 (2007) 57-63
83. Sheets E.E., Berman M.L., Hrountas C.K., Liao S.Y., and DiSaia P.J. Surgically treated, early-stage neuroendocrine small-cell cervical carcinoma. Obstet Gynecol 71 (1988) 10-14
84. Chang T.C., Lai C.H., Tseng C.J., Hsueh S., Huang K.G., and Chou H.H. Prognostic factors in surgically treated small cell cervical carcinoma followed by adjuvant chemotherapy. Cancer 83 (1998) 712-718
85. Viswanathan A.N., Deavers M.T., Jhingran A., Ramirez P.T., Levenback C., and Eifel P.J. Small cell neuroendocrine carcinoma of the cervix: outcome and patterns of recurrence. Gynecol Oncol 93 (2004) 27-33
86. Hoskins P.J., Swenerton K.D., Pike J.A., et al. Small-cell carcinoma of the cervix: fourteen years of experience at a single institution using a combined-modality regimen of involved-field irradiation and platinum-based combination chemotherapy. J Clin Oncol 21 (2003) 3495-3501
87. Chan J.K., Loizzi V., Burger R.A., Rutgers J., and Monk B.J. Prognostic factors in neuroendocrine small cell cervical carcinoma: a multivariate analysis. Cancer 97 (2003) 568-574
88. Lee J.M., Lee K.B., Nam J.H., et al. Prognostic factors in FIGO stage IB-IIA small cell neuroendocrine carcinoma of the uterine cervix treated surgically: results of a multi-center retrospective Korean study. Ann Oncol 19 (2008) 321-326
89. Tetu B., Ro J.Y., Ayala A.G., Johnson D.E., Logothetis C.J., and Ordonez N.G. Small cell carcinoma of the prostate. Part I. A clinicopathologic study of 20 cases. Cancer 59 (1987) 1803-1809
90. Sella A., Konichezky M., Flex D., Sulkes A., and Baniel J. Low PSA metastatic androgen-independent prostate cancer. Eur Urol 38 (2000) 250-254
91. Palmgren J.S., Karavadia S.S., and Wakefield M.R. Unusual and underappreciated: small cell carcinoma of the prostate. Sem Oncol 34 (2007) 22-29
92. Spiess P.E., Pettaway C.A., Vakar-Lopez F., et al. Treatment outcomes of small cell carcinoma of the prostate: a single-center study. Cancer 110 (2007) 1729-1737
93. Oesterling J.E., Hauzeur C.G., and Farrow G.M. Small cell anaplastic carcinoma of the prostate: a clinical, pathological and immunohistological study of 27 patients. J Urol 147 (1992) 804-807
94. Bolton D.M., Chiu S.T., Clarke S., and Angus D. Primary small cell carcinoma of the prostate: unusual modes of presentation. Aust N Z J Surg 64 (1994) 91-94
95. Asmis T.R., Reaume M.N., Dahrouge S., and Malone S. Genitourinary small cell carcinoma: a retrospective review of treatment and survival patterns at The Ottawa hospital regional cancer center. BJU Int 97 (2006) 711-715
96. Papandreou C.N., Daliani D.D., Thall P.F., et al. Results of a phase II study with doxorubicin, etoposide, and cisplatin in patients with fully characterized small-cell carcinoma of the prostate. J Clin Oncol 20 (2002) 3072-3080
97. Kageyama S., Narita M., Kim C.J., et al. Small cell carcinoma of the prostate: a report of three patients and a prognostic analysis of cases reported in Japan. Hinyokika Kiyo 52 (2006) 809-815
98. Moore S.R., Reinberg Y., and Zhang G. Small cell carcinoma of prostate: effectiveness of hormonal versus chemotherapy. Urology 39 (1992) 411-416
99. Lobins R., and Floyd J. Small cell carcinoma of unknown primary. Sem Oncol 34 (2007) 39-42
100. Papac R.J. Spontaneous regression of cancer: possible mechanisms. In Vivo 12 (1998) 571-578
101. Everson T. Spontaneous regression of cancer. Ann N Y Acad Sci 114 (1964) 721-735
102. Abbruzzese J.L., Lenzi R., Raber M.N., Pathak S., and Frost P. The biology of unknown primary tumors. Sem Oncol 20 (1993) 238-243
103. Van Der Gaast A., Verwey J., Prins E., and Splinter T.A. Chemotherapy as treatment of choice in extrapulmonary undifferentiated small cell carcinomas. Cancer 65 (1990) 422-424
104. Nugent J.L., Bunn Jr. P.A., Matthews M.J., et al. CNS metastases in small cell bronchogenic carcinoma: increasing frequency and changing pattern with lengthening survival. Cancer 44 (1979) 1885-1893
105. Auperin A., Arriagada R., Pignon J.P., et al. Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission. Prophylactic cranial irradiation overview collaborative group. N Engl J Med 341 (1999) 476-484
106. Murray N., Coy P., Pater J.L., et al. Importance of timing for thoracic irradiation in the combined modality treatment of limited-stage small-cell lung cancer. The National Cancer Institute of Canada clinical trials group. J Clin Oncol 11 (1993) 336-344
107. Johnson B.E., Bridges J.D., Sobczeck M., et al. Patients with limited-stage small-cell lung cancer treated with concurrent twice-daily chest radiotherapy and etoposide/cisplatin followed by cyclophosphamide, doxorubicin, and vincristine. J Clin Oncol 14 (1996) 806-813
108. Gregor A., Cull A., Stephens R.J., et al. Prophylactic cranial irradiation is indicated following complete response to induction therapy in small cell lung cancer: results of a multicentre randomised trial. United Kingdom Coordinating Committee for Cancer Research (UKCCCR) and the European Organization for Research and Treatment of Cancer (EORTC). Eur J Cancer 33 (1997) 1752-1758
109. Grosshans D.R., Meyers C.A., Allen P.K., Davenport S.D., and Komaki R. Neurocognitive function in patients with small cell lung cancer: effect of prophylactic cranial irradiation. Cancer 112 (2008) 589-595
110. Komaki R., Meyers C.A., Shin D.M., et al. Evaluation of cognitive function in patients with limited small cell lung cancer prior to and shortly following prophylactic cranial irradiation. Int J Radiat Oncol Biol Phys 33 (1995) 179-182
111. Slotman B., Faivre-Finn C., Kramer G., et al. Prophylactic cranial irradiation in extensive small-cell lung cancer. N Engl J Med 357 (2007) 664-672
112. Soto D.E., and Eisbruch A. Limited-stage extrapulmonary small cell carcinoma: outcomes after modern chemotherapy and radiotherapy. Cancer J 13 (2007) 243-246
113. Hussein A.M., Feun L.G., Sridhar K.S., Otrakji C.L., Garcia-Moore M., and Benedetto P. Small cell carcinoma of the large intestine presenting as central nervous systems signs and symptoms. Two case reports with literature review. J Neurooncol 8 (1990) 269-274
114. Ali S.Z., Reuter V.E., and Zakowski M.F. Small cell neuroendocrine carcinoma of the urinary bladder. A clinicopathologic study with emphasis on cytologic features. Cancer 79 (1997) 356-361
115. Lester J.F., Hudson E., and Barber J.B. Bladder preservation in small cell carcinoma of the urinary bladder: an institutional experience and review of the literature. Clin Oncol (R Coll Radiol) 18 (2006) 608-611
116. Weed Jr. J.C., Graff A.T., Shoup B., and Tawfik O. Small cell undifferentiated (neuroendocrine) carcinoma of the uterine cervix. J Am Coll Surg 197 (2003) 44-51
117. Tremont-Lukats I.W., Bobustuc G., Lagos G.K., Lolas K., Kyritsis A.P., and Puduvalli V.K. Brain metastasis from prostate carcinoma: The M.D. Anderson Cancer Center experience. Cancer 98 (2003) 363-368